Table 1.
Method | Advantages | Disadvantages | Direction of potential bias | Comments |
---|---|---|---|---|
Physician’s assessment | Simple Cheap Requires no structured tool |
Subjective Inaccurate Adherence estimates may affect/be affected by physician-patient relationship |
No particular bias |
De facto manner in which adherence is usually assessed Inaccurate both for predicting adherence and non-adherence [31-33] One study noted that physicians correctly rated their patients’ adherence 40% of the time [3] |
Patient self-report | Simple Cheap Allows qualitative assessment of adherence |
Subjective Inaccurate Accuracy can be affected by: poor patient recall, failure to recognize mistimed doses, dose missed over holidays/weekends as non-adherence, lack of patient candor |
Overestimates adherence | Currently the most widely-used adherence measure More accurate for predicting non-adherence than high adherence [20] Encompasses a variety of techniques, including unstructured interviews, visual analog scales, and standardized questionnaires One study found that patients recalled only 41% of documented visits, while 28% recalled visits that never occurred [34] One study found that of patients who denied missing any protease inhibitor doses, 50% had undetectable levels [35] |
Pill counts | Simple Cheap Objective |
Accuracy can be affected by: throwing away remaining pills prior to seeing provider (pill dumping), inability to confirm who took pills, no information on timing of doses | Overestimates adherence | Frequently used in research alone or in combination with to patient self-report |
Pharmacy refill records | Objective | Requires that patients bring in bottles Accuracy can be affected by: inability to confirm who took pills, inability to confirm timing of doses taken Requires capacity to maintain records and track patients over time |
Overestimates adherence | Evidence has linked high refill rates with improved outcomes [36] Frequently used in research in addition to patient self-report |
Drug level monitoring | Objective | Expensive Technically difficult (requires laboratory, testing capacity) Invasive (requires blood draws) Accuracy can be affected by: limited time frame of test effectiveness (3–4 days), inability to confirm timing of doses taken Requires baseline PK profile of population under study for accurate interpretation of results |
Can overestimate or underestimate depending on: patient behavior immediately preceding test genetic variations in drug metabolism | One study found that patients with low ratios of observed to predicted concentrations of efavirenz were less likely to have UDVL [37] |
Electronic drug monitoring | Objective Provides data on timing of doses taken Permits monitoring over long periods |
Expensive Requires training, computer, operator, and specialized pill bottles Intrusive (patients may resent being monitored) Accuracy can be affected by: inability to confirm who took pills Incompatible with pill trays |
Underestimates adherence (patients may take out multiple doses at a time for later use) | EDM more accurately predicts UDVL than self-report or pill count [19] |
UDVL, Undetectable viral load; PK, Pharmacokinetic; EDM, electronic drug monitor.